Sponsor pipeline

Portage Biotech clinical trial pipeline

Get alerts when Portage Biotech's trials change

1 active trials 1 recruiting 5 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-16
Primary completion pushed: 2026-06-01 → 2028-12-01
Enrollment reduced: 90 → 35 participants
Completion pushed: 2027-12-31 → 2029-03-01
NCT04969315 TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected… · Phase 1/2

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT04969315 TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected… Renal Cell Cancer Recruiting 2026-09-15

Disease areas by active trials

Kidney Cancer (1) · Lung Cancer (1) · Mesothelioma (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Prostate Cancer (1)

Get alerts when Portage Biotech's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free